PhRMA "Re-Repositioning"? Working Group Studying Rx Affordability Ahead Of Annual Meeting
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer exec Katen is overseeing group studying access and affordability issues. Association hopes to build on spirit of "repositioning" work that led to marketing guidelines in 2002.